The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
Open accessAbstract
The low-density lipoprotein receptor–related protein (Lrp)-5 functions as a Wnt coreceptor. Here we show that mice with a targeted disruption of Lrp5 develop a low bone mass phenotype. In vivo and in vitro analyses indicate that this phenotype becomes evident postnatally, and demonstrate that it is secondary to decreased osteoblast proliferation and function in a Cbfa1-independent manner. Lrp5 is expressed in osteoblasts and is required for optimal Wnt signaling in osteoblasts. In addition, Lrp5-deficient mice display persistent embryonic eye vascularization due to a failure of macrophage-induced endothelial cell apoptosis. These results implicate Wnt proteins in the postnatal control of vascular regression and bone formation, two functions affected in many diseases. Moreover, these features recapitulate human osteoporosis-pseudoglioma syndrome, caused by LRP5 inactivation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that loss-of-function mutations in the Wnt receptor LRP5 results in low bone mass in both humans (47) and mice (48), the down-regulation of sFRP4, taken together with changes in levels of several Wnt inhibitors, suggests that altered Wnt signaling may play a role in bone loss resulting from exposure to microgravity and that the protective effect of ACVR2B/Fc on microgravity-induced bone loss”
From Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight (2020) · cites this paper as [48]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“By using co-immunoprecipitation, several group reported that LRP6 can bind Wnt1, Wnt3a and Xenopus Wnt8 (Tamai et al., 2000;Mao et al., 2001;Kato et al., 2002;Itasaki et al., 2003;Liu et al., 2003).”
From Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding (2005) · cites this paper as Kato et al., 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,030
The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain
McMahon, A. P., & Bradley, A. (1990) · Cell · doi:10.1016/0092-8674(90)90385-r · Cited by 1,540
A new member of the frizzled family from Drosophila functions as a Wingless receptor
Bhanot, P., van den Brink, M. R. M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D. J., Nathans, J., & Nusse, R. (1996) · Nature · doi:10.1038/382225a0 · Cited by 1,504
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Female development in mammals is regulated by Wnt-4 signalling
Vainio, S. J., Heikkilä, M. M., Kispert, A., Chin, N., & McMahon, A. P. (1999) · Nature · doi:10.1038/17068 · Cited by 1,263
Flagged first, then by citations
Research works printed but not linked: 8
- 1996, Am. J. Hum. Genet., 59, 146
- 2001, Curr. Opin. Genet. Dev., 5, 543
- 1993, Osteoporos. Int., 1, S54
- 1987, J. Bone Miner. Res., 6, 595
- 1998, Nature., 95, 707
- 1998, Cell., 97, 707
- 1986, Clin. Genet., 2, 185
- 1999, J. Mol. Med., 77, 306, 10.1007/s001090050356 · DOI
Cited by
Sorted by citations
Items 401–500 of 999
Poulter, J. A., Davidson, A. E., Ali, M., Gilmour, D. F., Parry, D. A., Mintz-Hittner, H. A., Carr, I., Bottomley, H. M., Long, V. W., Downey, L., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8629 · Cited by 75
PORCNmutations in focal dermal hypoplasia: coping with lethality
Bornholdt, D., Oeffner, F., König, A., Happle, R., Alanay, Y., Ascherman, J. A., Benke, P. J., Boente, M. D. C., van der Burgt, I., Chassaing, N., et al. (2009) · Human Mutation · doi:10.1002/humu.20992 · Cited by 76
Regulation of Bone Mass by Serotonin: Molecular Biology and Therapeutic Implications
Karsenty, G., & Yadav, V. K. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-090710-133426 · Cited by 75
Self-citationWnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
Chen, K., Fallen, S., Abaan, H. Ö., Hayran, M., Gonzalez, C., Wodajo, F., MacDonald, T., Toretsky, J. A., & Üren, A. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21595 · Cited by 74
Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH
Li, C., Xing, Q., Yu, B., Xie, H., Wang, W., Shi, C., Crane, J. L., Cao, X., & Wan, M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1962 · Cited by 79
Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
Genetos, D. C., Yellowley, C. E., & Loots, G. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017772 · Cited by 74
Differentiation potential of a mouse bone marrow stromal cell line
Allan, E. H., Ho, P. W. M., Umezawa, A., Hata, J.-I., Makishima, F., Gillespie, M. T., & Martin, T. J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10614 · Cited by 74
Haÿ, E., Nouraud, A., & Marie, P. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008284 · Cited by 73
Goel, S., Chin, E. N., Fakhraldeen, S. A., Berry, S. M., Beebe, D. J., & Alexander, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362137 · Cited by 72
Fjeld, K., Kettunen, P., Furmanek, T., Kvinnsland, I. H., & Luukko, K. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20285 · Cited by 73
The canonical Wnt/ß-catenin signaling pathway regulates Fgf signaling for early facial development
Wang, Y., Song, L., & Zhou, C. J. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.11.004 · Cited by 73
Bone Biology and Anabolic Therapies for Bone: Current Status and Future Prospects
Martin, T. J. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.1.8 · Cited by 74
Li, J., Walker, L. D., Tyagi, A. M., Adams, J., Weitzmann, M. N., & Pacifici, R. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2044 · Cited by 72
Efficacy of serotonin inhibition in mouse models of bone loss
Inose, H., Zhou, B., Yadav, V. K., Guo, X.-D. E., Karsenty, G., & Ducy, P. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.439 · Cited by 72
Self-citationNeven, E., Persy, V. P., Dauwe, S. E. H., Schutter, T. M. D., Broe, M. E. D., & D’Haese, P. C. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.204834 · Cited by 72
Increased glycolysis mediates Wnt7b‐induced bone formation
Chen, H., Ji, X., Lee, W., Shi, Y., Li, B., Abel, E. D., Jiang, D., Huang, W., & Long, F. (2019) · The FASEB Journal · doi:10.1096/fj.201900201rr · Cited by 72
Molecular genetics of too much bone
Janssens, K. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2385 · Cited by 72
Wnt-signaling in skeletal development
Teufel, S., & Hartmann, C. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.11.010 · Cited by 70
Self-citationBaliram, R., Latif, R., Berkowitz, J., Frid, S., Colaianni, G., Sun, L., Zaidi, M., & Davies, T. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110286108 · Cited by 71
Genetic disorders of the LRP5–Wnt signalling pathway affecting the skeleton
Koay, M. A., & Brown, M. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.01.004 · Cited by 72
The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases
Boudin, E., Fijałkowski, I., Piters, E., & Hul, W. V. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.01.004 · Cited by 74
Genetics in Endocrinology: Autosomal dominant osteopetrosis revisited: lessons from recent studies
Bollerslev, J., Henriksen, K., Nielsen, M. F., Brixen, K., & Hul, W. V. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0136 · Cited by 70
Wnt signalling in the mouse intestine
Clarke, A. R. (2006) · Oncogene · doi:10.1038/sj.onc.1210065 · Cited by 70
Dissecting Molecular Differences between Wnt Coreceptors LRP5 and LRP6
MacDonald, B. T., Semënov, M. V., Huang, H., & He, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023537 · Cited by 68
Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway
Mi, K., & Johnson, G. V. W. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20400 · Cited by 69
Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging
Chen, D., Xie, R., Shu, B., LANDAY, A. L., Wei, C., Reiser, J., Spagnoli, A., Torquati, A., Forsyth, C. B., Keshavarzian, A., et al. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13945 · Cited by 69
Luo, G., Liu, H., & Lu, H. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12777 · Cited by 70
Dominant Negative LRP5 Decreases Tumorigenicity and Metastasis of Osteosarcoma in an Animal Model
Guo, Y., Rubin, E. M., Xie, J., Zi, X., & Hoang, B. H. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0344-y · Cited by 68
The Importance of Wnt Signaling in Cardiovascular Development
Tian, Y., Cohen, E. D., & Morrisey, E. E. (2009) · Pediatric Cardiology · doi:10.1007/s00246-009-9606-z · Cited by 73
LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation
Zhang, J., Zhang, X., Zhang, L., Zhou, F., van Dinther, M., & ten Dijke, P. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1661 · Cited by 69
Macrophages as a Source and Recipient of Wnt Signals
Malsin, E. S., Kim, S.-J., Lam, A. P., & Gottardi, C. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01813 · Cited by 68
Bodine, P. V. N., Seestaller‐Wehr, L., Kharode, Y. P., Bex, F. J., & Komm, B. S. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20834 · Cited by 68
Heppner, K. M., & Tong, J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0183 · Cited by 68
Role of Wnt Signaling in Bone Remodeling and Repair
Issack, P. S., Helfet, D. L., & Lane, J. M. (2007) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-007-9072-1 · Cited by 69
Genetic Causes of Craniosynostosis: An Update
Goos, J. A. C., & Mathijssen, I. M. J. (2018) · Molecular Syndromology · doi:10.1159/000492266 · Cited by 68
GSK-3 inhibition by an orally active small molecule increases bone mass in rats
Marsell, R., Sisask, G., Nilsson, Y., Sundgren‐Andersson, A. K., Andersson, U., Larsson, S., Nilsson, O., Ljunggren, Ö., & Jonsson, K. B. (2011) · Bone · doi:10.1016/j.bone.2011.11.007 · Cited by 66
Signaling Pathways in Human Skeletal Dysplasias
Baldridge, D., Shchelochkov, O. A., Kelley, B., & Lee, B. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150158 · Cited by 67
Role of TCF/LEF Transcription Factors in Bone Development and Osteogenesis
Li, Z., Xu, Z., Duan, C., Liu, W., Sun, J., & Han, B. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.26741 · Cited by 67
Lymphocyte enhancer‐binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts
Kahler, R. A., Galindo, M. A., Lian, J. B., Stein, G. S., van Wijnen, A. J., & Westendorf, J. J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20702 · Cited by 67
Kulkarni, N. H., Wei, T., Kumar, A., Dow, E. R., Stewart, T. R., Shou, J., N'Cho, M., Sterchi, D. L., Gitter, B. D., Higgs, R. E., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21374 · Cited by 66
Li, G., Xu, J., & Li, Z. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.015 · Cited by 65
Chen, D., Li, Y., Zhou, Z., Xing, Y., Zhong, Y., Zou, X., Tian, W., & Zhang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052948 · Cited by 66
β-Catenin in the race to fracture repair: in it to Wnt
Silkstone, D., Hong, H., & Alman, B. A. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0838 · Cited by 65
Vascular Endothelial Growth Factor Expression and Signaling in the Lens
Shui, Y., Wang, X., Hu, J. S., Wang, S., Garcia, C. M., Potts, J. D., Sharma, Y., & Beebe, D. C. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1226 · Cited by 65
Function of BMPs and BMP Antagonists in Adult Bone
Abe, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.007 · Cited by 65
Sun, L., Davies, T. F., Blair, H. C., Abe, E., & Zaidi, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.033 · Cited by 65
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
Hiasa, M., Teramachi, J., Oda, A., Amachi, R., Harada, T., Nakamura, S., Miki, H., Fujii, S., Kagawa, K., Watanabe, K., et al. (2014) · Leukemia · doi:10.1038/leu.2014.147 · Cited by 66
Roles of Wnt signaling in bone formation and resorption
Kobayashi, Y., Maeda, K., & Takahashi, N. (2008) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2007.11.002 · Cited by 67
Koh, J., Jung, M. H., Hong, J. S., Park, H. J., Chang, J. S., Shin, H. D., Kim, S., & Kim, G. S. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.3.407 · Cited by 64
Lens induction in vertebrates: Variations on a conserved theme of signaling events
Donner, A. L., Lachke, S. A., & Maas, R. L. (2006) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2006.10.005 · Cited by 63
Nakamura, T., Nakamura, T., & Matsumoto, K. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00201.x · Cited by 66
Faverman, L., Mikhaylova, L. M., Malmquist, J., & Nurminskaya, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.053 · Cited by 63
MECHANISMS IN ENDOCRINOLOGY: Bone Marrow Adiposity and bone, a bad romance?
Rharass, T., & Lucas, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0182 · Cited by 42
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
Schulze, J., Seitz, S. A., Saito, H., Schneebauer, M., Marshall, R. P., Baranowsky, A., Busse, B., Schilling, A. F., Friedrich, F. W., Albers, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010309 · Cited by 63
Low doses and high doses of heparin have different effects on osteoblast‐like Saos‐2 cells in vitro
Hausser, H., & Brenner, R. E. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20007 · Cited by 62
HIF-1α Inhibits Wnt Signaling Pathway by Activating Sost Expression in Osteoblasts
Chen, D., Li, Y., Zhou, Z., Wu, C., Xing, Y., Zou, X., Tian, W., & Zhang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065940 · Cited by 65
Parmalee, N. L., & Kitajewski, J. (2008) · Current Drug Targets · doi:10.2174/138945008784911822 · Cited by 61
Wdr5 Is Essential for Osteoblast Differentiation
Zhu, E. D., Demay, M. B., & Gori, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703304200 · Cited by 58
Gene variants for osteoporosis and their pleiotropic effects in aging
Ferrari, S., & Rizzoli, R. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.01.002 · Cited by 63
Epigenetic modifications in osteogenic differentiation and transformation
Thomas, D. M., & Kansara, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20850 · Cited by 61
Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges
MacNabb, C., Patton, D., & Hayes, J. S. (2016) · Journal of Osteoporosis · doi:10.1155/2016/6217286 · Cited by 61
Smoum, R., Baraghithy, S., Chourasia, M., Breuer, A., Mussai, N., Attar-Namdar, M., Kogan, N. M., Raphael-Mizrahi, B., Bolognini, D., Cascio, M. G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503395112 · Cited by 60
Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass
Kram, V., Zcharia, E., Yacoby‐Zeevi, O., Metzger, S., Chajek‐Shaul, T., Gabet, Y., Müller, R., Vlodavsky, I., & Bab, I. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20625 · Cited by 60
Identifying genes that regulate bone remodeling as potential therapeutic targets
Krane, S. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050354 · Cited by 61
Zhang, M., Zhang, P., Liu, Y., Lv, L., Zhang, X., Liu, H., & Zhou, Y. (2017) · Scientific Reports · doi:10.1038/srep42841 · Cited by 60
Advances in Runx2 regulation and its isoforms
Li, Y.-L., & Xiao, Z.-S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.06.006 · Cited by 60
Effects of Secreted Frizzled-Related Protein 3 on Osteoblasts In Vitro
Chung, Y., Baylink, D. J., Srivastava, A. K., Amaar, Y. G., Tapia, B., Kasukawa, Y., & Mohan, S. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040412 · Cited by 60
Lrp5 and Lrp6 play compensatory roles in mouse intestinal development
Zhong, Z. A., Baker, J. J., Diegel, C. R., & Williams, B. O. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23324 · Cited by 59
LRP5 Is Required for Vascular Development in Deeper Layers of the Retina
Xia, C., Yablonka‐Reuveni, Z., & Gong, X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011676 · Cited by 59
TGF-β regulates sclerostin expression via the ECR5 enhancer
Loots, G. G., Keller, H., Leupin, O., Murugesh, D. K., Collette, N. M., & Genetos, D. C. (2011) · Bone · doi:10.1016/j.bone.2011.11.016 · Cited by 59
The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
Ml, J. (2004) · PubMed · Cited by 59
Regulation of Osteoblast Metabolism by Wnt Signaling
Moorer, M. C., & Riddle, R. C. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.3.318 · Cited by 60
Characterization of Wnt/β‐catenin signalling in osteoclasts in multiple myeloma
Qiang, Y., Chen, Y., Brown, N., Hu, B., Epstein, J., Barlogie, B., & Shaughnessy, J. D. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08009.x · Cited by 59
Nemoto, E., Ebe, Y., Kanaya, S., Tsuchiya, M., Nakamura, T., Tamura, M., & Shimauchi, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.039 · Cited by 57
Hruska, K. A., Mathew, S., Lund, R. J., Memon, I. A., & Saab, G. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.01.008 · Cited by 60
Miclea, R. L., Karperien, M., Bosch, C. A. J., van der Horst, G., van der Valk, M. A., Kobayashi, T., Kronenberg, H. M., Rawadi, G., Akçakaya, P., Löwik, C. W. G. M., et al. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-26 · Cited by 57
LRP receptor family member associated bone disease
Lara-Castillo, N., & Johnson, M. L. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9315-2 · Cited by 57
Novel Links among Wnt and TGF-β Signaling and Runx2
McCarthy, T. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0379 · Cited by 56
Wan, Y., Lu, C. Y., Cao, J., Zhou, R., Yao, Y., Yu, J., Zhang, L., Zhao, H., Li, H., Zhao, J., et al. (2013) · Bone · doi:10.1016/j.bone.2012.12.052 · Cited by 55
Xing, Q., Ye, Q., Fan, M., Zhou, Y., Xu, Q., & Sandham, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22201 · Cited by 57
Wu, L. Y., Wei, Q., Lv, Y., Xue, J., Zhang, B., Sun, Q., Xiao, T., Huang, R., Wang, P., Dai, X., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061519 · Cited by 56
Yadav, V. K., & Ducy, P. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05312.x · Cited by 55
Qiao, L., Kang, K. L., & Heo, J. S. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0107-6 · Cited by 54
The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Wagner, E. R., Zhu, G., Zhang, B., Luo, Q., Shi, Q., Huang, E., Gao, Y., Gao, J., Kim, S. H., Rastegar, F., et al. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104010014 · Cited by 69
Liu, S., Jin, D., Wu, J., Xu, Z.-Y., Fu, S., Mei, G., Zou, Z., & Ma, S. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.12.008 · Cited by 56
Fukuda, T., Kokabu, S., Ohte, S., Sasanuma, H., Kanomata, K., Yoneyama, K., Kato, H., Akita, M., Oda, H., & Katagiri, T. (2010) · Differentiation · doi:10.1016/j.diff.2010.05.002 · Cited by 54
Regulation of osteoblast differentiation by interleukin-11 via AP-1 and Smad signaling [Review]
Matsumoto, T., Kuriwaka-Kido, R., Kondo, T., Endo, I., & Kido, S. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0219 · Cited by 55
The importance of WNT pathways for bone metabolism and their regulation by implant topography
Galli, C., Piemontese, M., Lumetti, S., Manfredi, E., Gm, M., & Passeri, G. (2012) · European Cells and Materials · doi:10.22203/ecm.v024a04 · Cited by 55
Kwee, M. L., Balemans, W., Cleiren, E., Gille, J. J., van der Blij, F., Sepers, J. M., & Hul, W. V. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050303 · Cited by 54
Martin, A. C., Thornton, J. D., Liu, J., Wang, X., Zuo, J., Jablonski, M. M., Chaum, E., Zindy, F., & Skapek, S. X. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0349 · Cited by 53
Pannexin 3 Inhibits Proliferation of Osteoprogenitor Cells by Regulating Wnt and p21 Signaling
Ishikawa, M., Iwamoto, T., Fukumoto, S., & Yamada, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523241 · Cited by 55
Wnt/β-Catenin—A Canonical Tale of Cell-Fate Choice in the Vertebrate Skeleton
Kolpakova, E., & Olsen, B. R. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.04.008 · Cited by 53
Wnt Influence on Chondrocyte Differentiation and Cartilage Function
Yates, K. E., Shortkroff, S., & Reish, R. G. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.446 · Cited by 54
Ezura, Y., Nakajima, T., Urano, T., Sudo, Y., Kajita, M., Yoshida, H., Suzuki, T., Hosoi, T., Inoue, S., Shiraki, M., et al. (2007) · Bone · doi:10.1016/j.bone.2005.06.025 · Cited by 52
Zhang, Z., Qin, Y., He, J., Huang, Q., Li, M., Hu, Y.-Q., & Liu, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00173.x · Cited by 53
Ferrari, S., Deutsch, S., & Antonarakis, S. E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162326.62419.e4 · Cited by 52
Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding
Li, Y., Chen, J., Lu, W., McCormick, L. M., Wang, J., & Bu, G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02651 · Cited by 53
Berwick, D. C., Javaheri, B., Wetzel, A., Hopkinson, M., Nixon‐Abell, J., Grannò, S., Pitsillides, A. A., & Harvey, K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0153-4 · Cited by 54
Matrix Gla Protein Promotes the Bone Formation by Up-Regulating Wnt/β-Catenin Signaling Pathway
Zhang, J., Ma, Z.-R., Yan, K., Wang, Y., Yang, Y., & Wu, X. Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00891 · Cited by 52
Smith, A. J. P., Gidley, J., Sandy, J. R., Perry, M. J., Elson, C. J., Kirwan, J., Spector, T. D., Doherty, M., Bidwell, J. L., & Mansell, J. P. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.01.008 · Cited by 52
Metadata
- Authors
- Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., Lang, R. A., Karsenty, G., & Chan, L.
- Affiliations
- Baylor College of Medicine (US)
- 2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030
- University of Cincinnati (US)
- Harvard University (US)
- ORCID
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2002-04-15
- Volume
- 157
- Issue
- 2
- Pages
- 303-314
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2199263
- OpenAlex
- W2116610925
- Cited by
- 1,086
- References
- 46
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 18 · 2023: 13 · 2022: 21 · 2021: 24 · 2020: 33 · 2019: 27 · 2018: 26 · 2017: 40 · 2016: 27 · 2015: 39 · 2014: 56 · 2013: 65 · 2012: 61
- FWCI
- 22.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- March of Dimes Foundation
- Universiteit Utrecht
- National Institutes of Health (5r01dk058882-03, AR42919)
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (HL16512, R01HL016512, HL-51586, R01HL051586)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 58882)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR042919, AR42919)
- National Institute of Dental and Craniofacial Research (DE11290, R01DE011290)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- LRP5, Wnt signaling, osteoblast proliferation, osteopenia, vascular regression, endothelial cell apoptosis, macrophages, osteoporosis-pseudoglioma syndrome, bone formation, postnatal development
- MeSH terms
- Animals, Bone and Bones, Bone Development, Bone Diseases, Metabolic, Calcium, Cell Division, Eye, Eye Abnormalities, Immunohistochemistry, Macrophages, Neoplasm Proteins, Organ Size, Osteoblasts, Phenotype, Proto-Oncogene Proteins, Receptors, LDL, Transcription Factors, Signal Transduction, Mutagenesis, Site-Directed, Apoptosis, Mice, Knockout, Gene Expression Regulation, Developmental, In Situ Nick-End Labeling, LDL-Receptor Related Proteins, Zebrafish Proteins, Core Binding Factor Alpha 1 Subunit, Wnt Proteins, Mice, Low Density Lipoprotein Receptor-Related Protein-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
